stock split
23andMe to Undertake 1-for-20 Reverse Stock Split
The reverse stock split will reduce the number of the company's issued and outstanding common shares to about 25.8 million from nearly 517 million.
Singular Genomics Shares Soar on Deerfield Management Takeover Proposal
Funds and individuals associated with Deerfield control nearly 1 million shares of Singular, or approximately 27 percent of the firm, according to an SEC filing.
Ginkgo Bioworks Completes 1-for-40 Reverse Stock Split
The reverse stock split will reduce the number of outstanding common shares to about 51.4 million from approximately 2.05 billion.
OpGen to Execute 1-for-10 Reverse Stock Split
The reverse stock split is intended to bring the firm back into compliance with the Nasdaq's minimum bid price listing requirement of $1.00 per share.
Prenetics to Execute 1-for-15 Reverse Stock Split
The move, which will take effect Nov. 13, is intended to bring the company back into compliance with Nasdaq's minimum bid listing requirement of $1 per share.